Potential Therapeutic Relevance of CRISPR/Cas9 Guided Epigenetic Reg-ulations for Neuropsychiatric Disorders

  • Singh, D.D.; 
  • Verma, R.; 
  • Parimoo, P.; 
  • Sahu, A.; 
  • Kumar, V.; 
  • ... Yadav, D.K.; 
  • 외 1명
Citations

WEB OF SCIENCE

14
Citations

SCOPUS

15

초록

Brain function activity is regulated by several mechanisms of genetic and epigenetic fac-tors such as histone modelling, DNA methylation, and non-coding RNA. Alterations in these regulatory mechanisms affect the normal development of neurons that causes Neuropsychiatric Disorders (ND). However, it is required to analyse the functional significance of neuropsychiatric disorders associated with a molecular mechanism to bring about therapeutic advances in early diagnosis and treatment of the patients. The CRISPR/Cas 9 (Clustered Regularly Interspaced Short Palin-dromic Repeats) genome editing tools have revolutionized multiple genome and epigenome manipulation targets the same time. This review discussed the possibilities of using CRISPR/Cas 9 tools during molecular mechanism in the ND as a therapeutic approach to overcome ND that is caused due to genetic and epigenetic abnormalities. © 2021 Bentham Science Publishers.

키워드

CRISPR/Cas9; Epigenetic regulations; Gene editing; Neuronal development; Neuropsychiatric Disorders; Therapeutic applications; Transcription factor
제목
Potential Therapeutic Relevance of CRISPR/Cas9 Guided Epigenetic Reg-ulations for Neuropsychiatric Disorders
저자
Singh, D.D.; Verma, R.; Parimoo, P.; Sahu, A.; Kumar, V.; Upadhyay, E.; Yadav, D.K.
DOI
10.2174/1568026621666210317154502
발행일
2021-03
유형
Review
저널명
Current Topics in Medicinal Chemistry
권
21
호
10
페이지
878 ~ 894